Puneet Souda
Stock Analyst at Leerink Partners
(1.62)
# 3,032
Out of 4,829 analysts
213
Total ratings
47.4%
Success rate
-1.42%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $5.28 | +51.52% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $8.05 | +11.80% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $56.75 | +32.16% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $3.89 | +439.85% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $5.62 | -28.83% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $29.71 | +34.63% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $151.95 | -1.28% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $344.06 | +8.99% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.07 | +41.44% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $403.13 | +56.28% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $16.81 | +108.21% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $106.93 | +35.60% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $189.73 | +58.12% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $75.76 | +229.99% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $49.94 | +120.26% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $51.63 | +45.26% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $123.20 | +62.34% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.03 | +786.70% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.44 | +316.67% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $30.82 | -2.66% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $37.52 | +131.88% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $41.72 | +235.57% | 5 | Feb 24, 2022 |
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $5.28
Upside: +51.52%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $8.05
Upside: +11.80%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $56.75
Upside: +32.16%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $3.89
Upside: +439.85%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $5.62
Upside: -28.83%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $29.71
Upside: +34.63%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $151.95
Upside: -1.28%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $344.06
Upside: +8.99%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.07
Upside: +41.44%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $403.13
Upside: +56.28%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $16.81
Upside: +108.21%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $106.93
Upside: +35.60%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $189.73
Upside: +58.12%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $75.76
Upside: +229.99%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $49.94
Upside: +120.26%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $51.63
Upside: +45.26%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $123.20
Upside: +62.34%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.03
Upside: +786.70%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.44
Upside: +316.67%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $30.82
Upside: -2.66%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $37.52
Upside: +131.88%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $41.72
Upside: +235.57%